1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice
Latest trending news Ask a Whistleblower Attorney forum

BAD COMPANY ALL DIVISIONS

Discussion in 'American Pathology Partners' started by Anonymous, Mar 31, 2012 at 7:07 PM.

  1. #1 Anonymous, Mar 31, 2012 at 7:07 PM
    Anonymous

    Anonymous Guest

    NO STRUCTURE NO COMMISSIONS STAY AWAY!!!
     
    Quote
  2. #2 Anonymous, Mar 31, 2012 at 7:08 PM
    Anonymous

    Anonymous Guest

    AND HIGH TURNOVER!! SUCKY MANAGEMENT!!!
     
    Quote
  3. #3 Anonymous, Mar 31, 2012 at 7:44 PM
    Anonymous

    Anonymous Guest

    sucks 4 u
     
    Quote
  4. #4 Anonymous, Dec 1, 2012 at 7:56 PM
    Anonymous

    Anonymous Guest

    SUCKS ASS, ALL OF THEIR MADE UP SUCK AS COMPANIES DO! YOU WILL ONLY LAST LESS THAN A YEAR IF THAT!
     
    Quote
Reply to Thread